anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

150,721-150,780 of 319,975

filter-aware
06
arm | Investor Presentation Deck | 18 slidesarm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
07
arm | Investor Presentation Deck | 18 slidesarm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Market Size1 hit
08
The slide uses a three-stage timeline structure to illustrate the expansion of Arm technology.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
09
The chart shows exponential growth in annual shipments, with the final bar representing 22.8 billion units in 2019.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
10
The slide uses a waterfall chart to show license accumulation and a stacked area chart to show revenue contribution by license vintage.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
11
The slide uses a visual bridge/waterfall-like representation to show growth in market value over a decade.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
12
The slide uses a table-like structure to show growth projections for Arm's addressable markets.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
13
The slide uses a layered stack diagram to represent the various IP blocks (Software, Security, System, AI/ML, Vision, Graphics, Processor, Physical) that constitute Arm's product offering.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
14
The slide uses a visual metaphor of a stack of IP layers feeding into two investment pillars.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a vertical 'Device to Data Continuum' arrow as a primary structural element.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The slide illustrates the 'J-curve' or long-term investment nature of semiconductor R&D.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
17
The chart uses a dual-axis approach to correlate financial metrics with headcount growth.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Financials1 hit
18
arm | Investor Presentation Deck | 18 slidesarm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
01
Slide 1
Cover slide or mission statement slide.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
02
Includes date reference: June 13, 2022.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
03
The slide uses a numbered list to present five key pillars of the company's value proposition.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide highlights key leadership figures and their past company affiliations, followed by a quantitative summary of their regulatory track record.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
05
The slide uses a hierarchical structure to connect a high-level objective to three distinct operational pillars.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a Gantt-style visualization to show drug development progress.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
07
The slide uses a hub-and-spoke diagram to represent the company's decentralized model.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
08
The slide uses a timeline framework to contrast past performance with future expectations.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
09
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
10
The slide uses a split-layout: left side defines the condition and market size, right side outlines the clinical and regulatory pain points.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a line chart to demonstrate clinical efficacy over 12 weeks.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
12
Includes a dual-chart visualization comparing MADRS scores and CADSS scores from a third-party study.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
13
The slide uses chemical structures and bar charts to contrast the two enantiomers.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Competition1 hit
14
CADSS = Clinician Administered Dissociative States Scale. Data points are plotted over time (Baseline, 15m, 40m, 90m).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
15
The slide uses a timeline diagram to illustrate the clinical trial phases.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
16
The table uses checkmarks to indicate positive attributes for specific compounds.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
17
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
18
Uses a vertical timeline-style process diagram to list unmet needs.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
19
The slide uses a vertical process flow to map development stages to key de-risking milestones.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
20
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
21
The slide highlights positive cognitive signals from a Phase 2 study, specifically emphasizing the efficacy of lower doses of RL-007.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
22
CIAS stands for Cognitive Impairment Associated with Schizophrenia. qEEG is quantitative electroencephalography.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
23
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
24
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
25
The slide uses a combination of a list-based framework for the 'Massive Unaddressed Need' and a data-heavy section for 'Anxiety in numbers'.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
26
The slide uses a split-layout with a dark sidebar for key facts and a white main area for clinical data and trial design.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
27
The slide uses a checkmark matrix to highlight the competitive advantage of the company's lead asset against standard-of-care classes like SSRIs, SNRIs, and Benzodiazepines.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
28
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a combination of a map, metric callouts, and a vertical timeline-style list to quantify the market opportunity.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
30
Includes a line chart showing HCQN subscale scores over time and a process diagram for the ongoing trial.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
31
The table uses checkmarks to indicate positive attributes for various therapies, highlighting DMX-1002's unique profile.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
33
The slide uses a Venn-like grouping of logos to illustrate the company's ecosystem.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
34
The slide uses a three-column layout to detail specific biotech subsidiaries/partnerships.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
35
The slide uses a split-screen layout to contrast the DTx platform (Psyber, Introspect) with the data analytics platform (Metabolomics, digital biomarkers, research station).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
36
The slide uses a three-column layout to detail specific R&D approaches.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
37
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Financials1 hit
38
Includes a list of institutional investors at the bottom.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
39
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
40
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
41
The table compares four different compounds (COMP360, VLS-01, RLS-01, PCN-101) across various clinical and commercial dimensions.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
42
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
43
The slide combines electrophysiological data (LTP) with behavioral cognitive model results to support the drug's mechanism and efficacy.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
44
The slide highlights that RL-007 reverses memory deficits at the lowest dose and outperforms the standard of care (Aricept).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
45
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
46
The slide uses a split timeline to contrast early research with modern regulatory progress, punctuated by a Nixon quote.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
47
The slide uses a yellow background with three distinct columns for testimonials, each featuring a headshot, demographic info, and the substance used.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit